Pilot program

Discussion in 'Amgen' started by anonymous, Aug 4, 2020 at 11:55 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Otezla reps worst nightmare...

    1. no we are not excited to sell enbrel. Literally, not 1 otezla rep wants to have to sell enbrel

    2. No, we don’t want enbrel reps promoting otezla and ruining unprecedented growth quarter after quarter

    3. No we don’t want to follow the enbrel promotion model. Now that I’m seeing it, I absolutely understand why my offices hate enbrel reps

    4. Poor Ron, I can’t imagine how he feels watching Amgen destroy his salesforce. He built it from the ground up and structured it perfectly... but Amgen is slowly chipping away until it crumbles.
     

  2. anonymous

    anonymous Guest

    Different sales force, but the same idiotic rep mindset. You work for Amgen, now. If you don't like what you are being told to do, quit, and go find another company to overpay you for your skill set.
     
  3. anonymous

    anonymous Guest

    a lot of arrogance for 5% market share
     
  4. anonymous

    anonymous Guest

    For turning a worst in class drug into a multi billion dollar product? For growing sales every consecutive quarter for 6 years straight? For blowing expectations of peak sales out of the water in year 2 of promotion?

    If you’ve been in pharma long enough you know this game is nothing to do with whole sales. It’s about beating expectations which in turn affects stock price.

    Why would we quit? You know Amgen agreed to pay us 70k at target right? Plus contests? Plus retention bonuses? Plus 80k in stock?

    It’s not about quitting... it’s about the goofballs at Amgen having zero emotional intelligence. They honestly think otezla reps should be excited about this opportunity. Time to adjust expectations and change course, otherwise this pilot program will be unproductive.
     
  5. anonymous

    anonymous Guest

    Try to stay as far away from the Amgen model as possible to be successful.
     
  6. anonymous

    anonymous Guest

    I feel for ya guys, but wait till you hear about how you’ll also be selling Avsola to gastro.
     
  7. anonymous

    anonymous Guest

    First Domino will be Greg. Then the entirety of the brand marketing team. Then Ron will fold. He simply won't be able to accept the activity focus and the complete lack of emphasis on performance.

    Once he's gone, the good DMs that are young will leave. The old DMs that are good will play the game until May. The bad DMs will love it here.

    The good reps will all be gone by by early Spring. The bad reps will love it here. The less you sell, the better your SGA.

    I feel for you but the reality is that we bought you. You didn't buy us.

    Prepare for activity and mediocrity.
     
  8. anonymous

    anonymous Guest

    ...then shut up and do what you are told
     
  9. anonymous

    anonymous Guest

    ...now let me slobber you’re noggin
     
  10. anonymous

    anonymous Guest

    My Otezla rep is putting in 12 virtual calls a day-they will fit in just fine.
     
  11. anonymous

    anonymous Guest

    that’s a one off. Otezla call average is 3/day
     
  12. anonymous

    anonymous Guest

    Amgen average is 7 a day, 6 of which are faked. When you count a call as doing a engage with the front office clerk, you can make a bunch of calls.
     
  13. anonymous

    anonymous Guest

    This is exactly why the otezla sales force is a more successful sales force. We don’t do fake calls. There is no benefit to it. There are no reports berating or applauding call averages. It literally blows my mind to hear sales people have to fake call activity at other organizations. Otezla reps are accountable for their sales number and that’s it. There is no goal based system or market share algorithm designed to help those who didn’t sell last quarter or last year. You either sell or you’re gone. There is no hiding.
     
  14. anonymous

    anonymous Guest


    Well get used to Amgen, where sales don't matter. We claim we like to compete intensly and win, but we don't measure sales. We have a convoluted SGA system that no one discusses. All our measurements and pressure are around activity measures. If you are good at faking things like calls, you will do fine here. No great, but fine.

    Ask around. You can't find a single person outside of TO who can tell you how Enbrel did in any month this year. We don't know anything until we listen to earning like the public.

    Get it in your heads: we don't value sales.
     
  15. anonymous

    anonymous Guest

    Measuring call and frequency doesn’t matter in specialty sales where there are only a handful of customers.
     
  16. anonymous

    anonymous Guest

    Just because the drugs come from specialty pharmacy doesn’t mean it’s specialty sales.
     
  17. anonymous

    anonymous Guest

    Thousand Oak Mentality:

    1-for Kaiser, we need a singular, focused team because that's the best way to drive sales

    2-ugh, well we need to go the POD system that has failed so many times over the past 20 years with everyone else and have the Enbrel reps selling Otezla and the Otezla reps selling Enbrel - focus no longer counts

    Damnit, you have taken away my work of the past 6 years. I hustled and found ways to grow Kaiser. Do you know how many private cell phone numbers of Kaiser docs I have acquired. How do you think I get them to my programs.

    Co-promotion is a giant exercise that gives the Raticans of the world busy work, but it will destroy sales momentum.

    I'm gone as soon as I get my November payout. I will crush your ass once I start selling against you.
     
  18. anonymous

    anonymous Guest


    What exactly are they paying you for your payout to keep you lazy a$$ here
     
  19. anonymous

    anonymous Guest


    My retention bonus bitch. I'll make more on that alone than you will in your apartment outside Thousand Oaks. Come Christmas, I will be gone having pocketed over $100k from Amgen above my salary.

    Then I'll come back to haunt you as I sell the best JAK on the market while you fake calls all day long.
     
  20. anonymous

    anonymous Guest

    until amgen sues you for violating the non compete